Literature DB >> 27818231

Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.

Sarandeep S S Boyanapalli1, Wenji Li1, Francisco Fuentes1, Yue Guo1, Christina N Ramirez1, Ximena-Parades Gonzalez1, Douglas Pung1, Ah-Ng Tony Kong2.   

Abstract

Epigenetic silencing of tumor suppressor genes is a phenomenon frequently observed in multiple cancers. Ras-association domain family 1 isoform A (RASSF1A) is a well-characterized tumor suppressor that belongs to the Ras-association domain family. Several studies have demonstrated that hypermethylation of the RASSF1A promoter is frequently observed in lung, prostate, and breast cancers. Phenethyl isothiocyanate (PEITC), a phytochemical abundant in cruciferous vegetables, possesses chemopreventive activities; however, its potential involvement in epigenetic mechanisms remains elusive. The present study aimed to examine the role of PEITC in the epigenetic reactivation of RASSF1A and the induction of apoptosis in LNCaP cells. LNCaP cells were treated for 5days with 0.01% DMSO, 2.5 or 5μM PETIC or 2.5μM azadeoxycytidine (5-Aza) with 0.5μM trichostatin A (TSA). We evaluated the effects of these treatments on CpG demethylation using methylation-specific polymerase chain reaction (MSP) and bisulfite genomic sequencing (BGS). CpG demethylation was significantly enhanced in cells treated with 5μM PEITC and 5-Aza+TSA; therefore, the latter treatment was used as a positive control in subsequent experiments. The decrease in RASSF1A promoter methylation correlated with an increase in expression of the RASSF1A gene in a dose-dependent manner. To confirm that promoter demethylation was mediated by DNA methyltransferases (DNMTs), we analyzed the expression levels of DNMTs and histone deacetylases (HDACs) at the gene and protein levels. PEITC reduced DNMT1, 3A and 3B protein levels in a dose-dependent manner, and 5μM PEITC significantly reduced DNMT3A and 3B protein levels. HDAC1, 2, 4 and 6 protein expression was also inhibited by 5μM PEITC. The combination of 5-Aza and TSA, a DNMT inhibitor and a HDAC inhibitor, respectively, was used as a positive control as this treatment significantly inhibited both HDACs and DNMTs. The function of RASSF1A reactivation in promoting apoptosis and inducing G2/M cell cycle arrest was analyzed using flow-cytometry analysis with Annexin V and propidium iodide (PI). Growth inhibition effect on LNCaP cells were investigated by colony formation assay. In addition, we analyzed p21, caspase-3 and 7, Bax, and Cyclin B1 protein levels. Flow-cytometry analysis of cells stained with PI alone demonstrated that 5μM PEITC promotes early apoptosis and G2/M cell cycle arrest. Flow cytometry analysis of cells stained with Annexin V and PI also demonstrated an increased proportion of cells in early apoptosis in cells treated with 5μM PEITC or 5-Aza with TSA. PEITC and efficiently inhibit colony numbers and total area. In addition, 5μM PEITC significantly enhanced p21, caspase-3, 7 and Bax levels and reduced Cyclin B1 expression compared with the control group. Collectively, the results of our study suggest that PEITC induces apoptosis in LNCaP cells potentially by reactivating RASSF1A via epigenetic mechanisms.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Demethylation; Epigenetics; Histone deacetylation; Phenenthyl isothiocyanate; Prostate cancer; RASSF1A; Tumor suppressor

Mesh:

Substances:

Year:  2016        PMID: 27818231      PMCID: PMC5396455          DOI: 10.1016/j.phrs.2016.10.021

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  72 in total

1.  Cruciferous vegetables, isothiocyanates, and prevention of bladder cancer.

Authors:  Omkara L Veeranki; Arup Bhattacharya; Li Tang; James R Marshall; Yuesheng Zhang
Journal:  Curr Pharmacol Rep       Date:  2015-08

2.  Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB.

Authors:  Wen-Jing Shen; Dong-Qiu Dai; Yue Teng; Hong-Bo Liu
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

3.  Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.

Authors:  M G Lee; H Y Kim; D S Byun; S J Lee; C H Lee; J I Kim; S G Chang; S G Chi
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

Review 4.  The tumor suppressor RASSF1A in human carcinogenesis: an update.

Authors:  R Dammann; U Schagdarsurengin; C Seidel; M Strunnikova; M Rastetter; K Baier; G P Pfeifer
Journal:  Histol Histopathol       Date:  2005-04       Impact factor: 2.303

Review 5.  The epigenomics of cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

Review 6.  Methylation of the RASSF1A gene in human cancers.

Authors:  Gerd P Pfeifer; Jung-Hoon Yoon; Limin Liu; Stella Tommasi; Sharon P Wilczynski; Reinhard Dammann
Journal:  Biol Chem       Date:  2002-06       Impact factor: 3.915

7.  The prognostic value of Cyclin B1 in pancreatic cancer.

Authors:  Li Zhou; Jian Li; Yu-Pei Zhao; Quan-Cai Cui; Wei-Xun Zhou; Jun-Chao Guo; Lei You; Wen-Ming Wu; Tai-Ping Zhang
Journal:  Med Oncol       Date:  2014-08-09       Impact factor: 3.064

8.  RASSF1A Promoter Methylation Levels Positively Correlate with Estrogen Receptor Expression in Breast Cancer Patients.

Authors:  Viera Kajabova; Bozena Smolkova; Iveta Zmetakova; Katarina Sebova; Tomas Krivulcik; Vladimir Bella; Karol Kajo; Katarina Machalekova; Ivana Fridrichova
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

9.  Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention.

Authors:  Dean Ornish; Mark Jesus M Magbanua; Gerdi Weidner; Vivian Weinberg; Colleen Kemp; Christopher Green; Michael D Mattie; Ruth Marlin; Jeff Simko; Katsuto Shinohara; Christopher M Haqq; Peter R Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-16       Impact factor: 11.205

10.  Aberrant DNA methylation and prostate cancer.

Authors:  Sunipa Majumdar; Eric Buckles; John Estrada; Shahriar Koochekpour
Journal:  Curr Genomics       Date:  2011-11       Impact factor: 2.236

View more
  17 in total

1.  Lysophosphatidic Acid Receptor 6 (LPAR6) Expression and Prospective Signaling Pathway Analysis in Breast Cancer.

Authors:  Kai Tao; Shipeng Guo; Rui Chen; Chengcheng Yang; Lei Jian; Haochen Yu; Shengchun Liu
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

Review 2.  CpG and Non-CpG Methylation in the Diet-Epigenetics-Neurodegeneration Connection.

Authors:  Andrea Fuso; Marco Lucarelli
Journal:  Curr Nutr Rep       Date:  2019-06

3.  PTEN deletion drives aberrations of DNA methylome and transcriptome in different stages of prostate cancer.

Authors:  Chao Wang; Yaping Feng; Chengyue Zhang; David Cheng; Renyi Wu; Yuqing Yang; Davit Sargsyan; Dibyendu Kumar; Ah-Ng Kong
Journal:  FASEB J       Date:  2019-11-29       Impact factor: 5.191

4.  DNMT1-mediated demethylation of lncRNA MEG3 promoter suppressed breast cancer progression by repressing Notch1 signaling pathway.

Authors:  Tingting Pan; Haiwen Ding; Le Jin; Shaobo Zhang; Delin Wu; Wanwan Pan; Menghao Dong; Xiaopeng Ma; Zhaolin Chen
Journal:  Cell Cycle       Date:  2022-07-13       Impact factor: 5.173

5.  Benzyl and phenethyl isothiocyanates as promising epigenetic drug compounds by modulating histone acetylation and methylation marks in malignant melanoma.

Authors:  Melina Mitsiogianni; Ioannis Anestopoulos; Sotiris Kyriakou; Dimitrios T Trafalis; Rodrigo Franco; Aglaia Pappa; Mihalis I Panayiotidis
Journal:  Invest New Drugs       Date:  2021-05-08       Impact factor: 3.850

Review 6.  Association of Smoking, Alcohol Use, and Betel Quid Chewing with Epigenetic Aberrations in Cancers.

Authors:  Tong-Hong Wang; Shih-Min Hsia; Yin-Hwa Shih; Tzong-Ming Shieh
Journal:  Int J Mol Sci       Date:  2017-06-06       Impact factor: 5.923

Review 7.  Targeting DNA Methyltranferases in Urological Tumors.

Authors:  Ângela Marques-Magalhães; Inês Graça; Rui Henrique; Carmen Jerónimo
Journal:  Front Pharmacol       Date:  2018-04-13       Impact factor: 5.810

Review 8.  Impact of Natural Compounds on DNA Methylation Levels of the Tumor Suppressor Gene RASSF1A in Cancer.

Authors:  Reinhard H Dammann; Antje M Richter; Adriana P Jiménez; Michelle Woods; Miriam Küster; Chamindri Witharana
Journal:  Int J Mol Sci       Date:  2017-10-17       Impact factor: 5.923

9.  Activation of SIRT6 by DNA hypomethylating agents and clinical consequences on combination therapy in leukemia.

Authors:  Hetty E Carraway; Sridhar A Malkaram; Yana Cen; Aymen Shatnawi; Jun Fan; Hamdy E A Ali; Zakaria Y Abd Elmageed; Thomm Buttolph; James Denvir; Donald A Primerano; Tamer E Fandy
Journal:  Sci Rep       Date:  2020-06-25       Impact factor: 4.379

10.  Sulforaphane and iberin are potent epigenetic modulators of histone acetylation and methylation in malignant melanoma.

Authors:  Melina Mitsiogianni; Dimitrios T Trafalis; Rodrigo Franco; Vasilis Zoumpourlis; Aglaia Pappa; Mihalis I Panayiotidis
Journal:  Eur J Nutr       Date:  2020-03-25       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.